GW Hematology and Medical Oncology 2026: Overview
The GW Hematology and Medical Oncology 2026 Best Practices course reviews benign blood disorders, hematologic malignancies and solid tumors in a board-oriented format. The curriculum includes transfusion medicine, thrombosis, transplantation, antineoplastic pharmacology and cellular therapies, alongside disease-specific oncology sessions.
Directed by Robert S. Siegel, MD, the original meeting took place August 7–13, 2026, in Arlington, Virginia. This review is intended for hematology and oncology fellows, board candidates and practicing clinicians. The detailed session list below shows the scope of the home-study and conference material.
Learning Objectives
Hematology
Upon completion of the original educational program, learners should be better able to:
- Understand established concepts and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors.
- Review developments in coagulopathies, anticoagulant treatment, and thrombolytic therapies.
- Interpret blood and bone marrow morphology in the context of hematopathology.
- Recognize and evaluate red blood cell disorders.
Hematologic Malignancies
- Understand recent developments in the pharmacology and toxicology of antineoplastic medications.
- Evaluate and manage major hematologic malignancies according to contemporary evidence.
- Apply effective strategies when preparing for Hematology and Medical Oncology board examinations.
Medical Oncology
- Understand the epidemiology of malignant diseases and approaches to managing cancer-related medical complications.
- Review management principles for gynecologic and genitourinary malignancies.
- Recognize advances in the diagnosis and treatment of lung, breast, and gastrointestinal cancers.
- Understand emerging biologic and immune-based cancer therapies.
- Review clinical challenges involving HIV-associated malignancies.
Topics
The on-demand curriculum covers the following detailed sessions and lectures:
-
Day 0: Hematology / Oncology Enduring Courses
-
Biology of Hematopoiesis
-
Anemia of Chronic Illness
-
Megaloblastic and Sideroblastic Anemias
-
Porphyrias
-
Red Cell Enzymes, Membranes, and Metabolism
-
Mechanisms for Clotting
-
Oral Anticoagulants and Antithrombotic Therapy
-
Parenteral Antithrombotics and Thrombolytic Therapy
-
Review of Cellular Morphology
-
Liquid Biopsies
-
Mesothelioma
-
-
Day 1: Hematology Session
-
ITP and Drug-Induced Thrombocytopenia
-
Hemolytic Anemia
-
Consumptive Thrombohemorrhagic Disorders (DIC, TTP, HUS)
-
The Hemophilias
-
Hypercoagulable States
-
Von Willebrand’s Disease
-
Qualitative Platelet Defects
-
Acquired Disorders of Coagulation
-
Transfusion Medicine
-
Platelet Alloimmunization
-
-
Day 2: Hematology Session
-
Iron Deficiency and Overload
-
Hemoglobinopathies
-
Bone Marrow Failure
-
White Cell Disorders
-
Anti-PF4 Disorders (HIT, VITT), DIC and Ischemic Limb Gangrene
-
Sickling Disorders
-
ABO Incompatibility and Other Transfusion-Related Issues in Hematopoietic Transplantation
-
Hematologic Complications of Pregnancy
-
-
Day 3: Hematologic Malignancies
-
Pathology of Lymphomas
-
Non-Hodgkin’s Lymphoma
-
Myelodysplasia
-
Hodgkin’s Lymphoma
-
Acute Lymphocytic Leukemia
-
Chronic Myeloid Leukemia
-
Multiple Myeloma, Plasmacytoma, and MGUS
-
Waldenstrom’s Macroglobulinemia and Amyloidosis
-
Palliative Care
-
-
Day 4: Hematologic Malignancies
-
Acute Myeloid Leukemia
-
Bone Marrow Transplantation
-
Myeloproliferative Neoplasms
-
Pharmacology I
-
Chronic Lymphocytic Leukemia
-
Pharmacology II
-
Pharmacology III
-
T Cell Therapies for Cancer
-
-
Day 5: Oncology Session
-
Melanoma
-
Familial Cancer Syndromes
-
Non-Small Cell Lung Cancer
-
Small Cell Lung Cancer
-
Adjuvant Therapy for Breast Cancer
-
Metastatic Breast Cancer
-
Neuro-Oncology
-
Metastatic Disease to the Brain, Spine, Carcinomatous Meningitis
-
Endocrine Malignancies
-
-
Day 6: Oncology Session
-
Renal Cell Cancer
-
Prostate Cancer
-
Bladder Cancer
-
Testicular Cancer and Mediastinal Germ Cell Tumors
-
Ovarian Cancer
-
Endometrial Cancer
-
Cancer of the Cervix, Vulva, Vagina and Gestational Trophoblastic Tumors
-
Head and Neck Cancer
-
Carcinoid Tumors, Carcinoid Syndrome and Pancreatic Neuroendocrine Tumors
-
-
Day 7: Oncology Session
-
Esophageal Carcinoma
-
Gastric Cancer
-
Adjuvant Therapy for Colon and Rectal Cancer
-
Pancreatic Cancer
-
Metastatic Therapy for Colon and Rectal Cancer
-
Anal Cancer
-
Sarcoma
-
Hepatobiliary Cancer
-



